Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients.

Lasho TL, Finke CM, Hanson CA, Jimma T, Knudson RA, Ketterling RP, Pardanani A, Tefferi A.

Leukemia. 2012 May;26(5):1135-7. doi: 10.1038/leu.2011.320. Epub 2011 Nov 8. No abstract available.

PMID:
22064353
[PubMed - indexed for MEDLINE]
2.

Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome.

Mian SA, Smith AE, Kulasekararaj AG, Kizilors A, Mohamedali AM, Lea NC, Mitsopoulos K, Ford K, Nasser E, Seidl T, Mufti GJ.

Haematologica. 2013 Jul;98(7):1058-66. doi: 10.3324/haematol.2012.075325. Epub 2013 Jan 8.

PMID:
23300180
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Frequent pathway mutations of splicing machinery in myelodysplasia.

Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, Chalkidis G, Suzuki Y, Shiosaka M, Kawahata R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Ishiyama K, Mori H, Nolte F, Hofmann WK, Miyawaki S, Sugano S, Haferlach C, Koeffler HP, Shih LY, Haferlach T, Chiba S, Nakauchi H, Miyano S, Ogawa S.

Nature. 2011 Sep 11;478(7367):64-9. doi: 10.1038/nature10496.

PMID:
21909114
[PubMed - indexed for MEDLINE]
4.

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia.

Chesnais V, Kosmider O, Damm F, Itzykson R, Bernard OA, Solary E, Fontenay M.

Oncotarget. 2012 Nov;3(11):1284-93. Review.

PMID:
23327988
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.

Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo-Curtis C, Della Valle V, Couronné L, Scourzic L, Chesnais V, Guerci-Bresler A, Slama B, Beyne-Rauzy O, Schmidt-Tanguy A, Stamatoullas-Bastard A, Dreyfus F, Prébet T, de Botton S, Vey N, Morgan MA, Cross NC, Preudhomme C, Birnbaum D, Bernard OA, Fontenay M; Groupe Francophone des Myélodysplasies.

Blood. 2012 Apr 5;119(14):3211-8. doi: 10.1182/blood-2011-12-400994. Epub 2012 Feb 17.

PMID:
22343920
[PubMed - indexed for MEDLINE]
Free Article
6.

Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders.

Visconte V, Makishima H, Maciejewski JP, Tiu RV.

Leukemia. 2012 Dec;26(12):2447-54. doi: 10.1038/leu.2012.130. Epub 2012 May 15. Review.

PMID:
22678168
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies.

Damm F, Nguyen-Khac F, Fontenay M, Bernard OA.

Leukemia. 2012 Sep;26(9):2027-31. doi: 10.1038/leu.2012.86. Epub 2012 Apr 9. Review.

PMID:
22484420
[PubMed - indexed for MEDLINE]
8.

[Deregulated splicing machinery in myelodysplastic syndromes].

Ogawa S.

Rinsho Ketsueki. 2012 May;53(5):493-6. Review. Japanese. No abstract available.

PMID:
22728550
[PubMed - indexed for MEDLINE]
9.

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.

Cazzola M, Rossi M, Malcovati L; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative.

Blood. 2013 Jan 10;121(2):260-9. doi: 10.1182/blood-2012-09-399725. Epub 2012 Nov 16. Review.

PMID:
23160465
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, Godfrey AL, Rapado I, Cvejic A, Rance R, McGee C, Ellis P, Mudie LJ, Stephens PJ, McLaren S, Massie CE, Tarpey PS, Varela I, Nik-Zainal S, Davies HR, Shlien A, Jones D, Raine K, Hinton J, Butler AP, Teague JW, Baxter EJ, Score J, Galli A, Della Porta MG, Travaglino E, Groves M, Tauro S, Munshi NC, Anderson KC, El-Naggar A, Fischer A, Mustonen V, Warren AJ, Cross NC, Green AR, Futreal PA, Stratton MR, Campbell PJ; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium.

N Engl J Med. 2011 Oct 13;365(15):1384-95. doi: 10.1056/NEJMoa1103283. Epub 2011 Sep 26.

PMID:
21995386
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts.

Cui R, Gale RP, Xu Z, Qin T, Fang L, Zhang H, Pan L, Zhang Y, Xiao Z.

Leuk Res. 2012 Nov;36(11):1428-33. doi: 10.1016/j.leukres.2012.08.015. Epub 2012 Aug 23.

PMID:
22921018
[PubMed - indexed for MEDLINE]
12.

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value.

Patnaik MM, Lasho TL, Hodnefield JM, Knudson RA, Ketterling RP, Garcia-Manero G, Steensma DP, Pardanani A, Hanson CA, Tefferi A.

Blood. 2012 Jan 12;119(2):569-72. doi: 10.1182/blood-2011-09-377994. Epub 2011 Nov 17.

PMID:
22096241
[PubMed - indexed for MEDLINE]
Free Article
13.

[New insight into myelodysplastic syndromes and related myeloid disorders].

Ogawa S.

Rinsho Ketsueki. 2013 Jun;54(6):533-7. Review. Japanese. No abstract available.

PMID:
23823091
[PubMed - indexed for MEDLINE]
14.

SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications.

Damm F, Thol F, Kosmider O, Kade S, Löffeld P, Dreyfus F, Stamatoullas-Bastard A, Tanguy-Schmidt A, Beyne-Rauzy O, de Botton S, Guerci-Bresler A, Göhring G, Schlegelberger B, Ganser A, Bernard OA, Fontenay M, Heuser M.

Leukemia. 2012 May;26(5):1137-40. doi: 10.1038/leu.2011.321. Epub 2011 Nov 8. No abstract available.

PMID:
22064355
[PubMed - indexed for MEDLINE]
15.

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival.

Lasho TL, Jimma T, Finke CM, Patnaik M, Hanson CA, Ketterling RP, Pardanani A, Tefferi A.

Blood. 2012 Nov 15;120(20):4168-71. doi: 10.1182/blood-2012-05-429696. Epub 2012 Sep 11.

PMID:
22968464
[PubMed - indexed for MEDLINE]
Free Article
16.

When splicing turns bad.

Cools J.

Haematologica. 2012 Jan;97(1):1. doi: 10.3324/haematol.2011.060996. No abstract available.

PMID:
22210325
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.

Thol F, Kade S, Schlarmann C, Löffeld P, Morgan M, Krauter J, Wlodarski MW, Kölking B, Wichmann M, Görlich K, Göhring G, Bug G, Ottmann O, Niemeyer CM, Hofmann WK, Schlegelberger B, Ganser A, Heuser M.

Blood. 2012 Apr 12;119(15):3578-84. doi: 10.1182/blood-2011-12-399337. Epub 2012 Mar 2.

PMID:
22389253
[PubMed - indexed for MEDLINE]
Free Article
18.

[Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: IV. Recent topics of hematopoiesis; 1. Novel molecular mechanism of myelodysplastic syndromes].

Yoshida K, Sanada M, Ogawa S.

Nihon Naika Gakkai Zasshi. 2012 Jul 10;101(7):1994-2001. Japanese. No abstract available.

PMID:
22897004
[PubMed - indexed for MEDLINE]
19.

The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients.

Ohyashiki K, Aota Y, Akahane D, Gotoh A, Miyazawa K, Kimura Y, Ohyashiki JH.

Leukemia. 2005 Dec;19(12):2359-60. No abstract available.

PMID:
16239910
[PubMed - indexed for MEDLINE]
20.

The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.

Kremer M, Horn T, Dechow T, Tzankov A, Quintanilla-Martínez L, Fend F.

Leukemia. 2006 Jul;20(7):1315-6. Epub 2006 Apr 13. No abstract available.

PMID:
16617316
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk